
-
Zelensky urges allies to seek 'regime change' in Russia
-
Trump envoy to inspect Gaza aid as pressure mounts on Israel
-
US theater and opera legend Robert Wilson dead at 83
-
EA shooter 'Battlefield 6' to appear in October
-
Heavyweight shooter 'Battlefield 6' to appear in October
-
Justin Timberlake says he has Lyme disease
-
Atkinson and Tongue strike as India struggle in England decider
-
US theater and opera auteur Bob Wilson dead at 83
-
Trump envoy to visit Gaza as pressure mounts on Israel
-
In Darwin's wake: Two-year global conservation voyage sparks hope
-
Microsoft valuation surges above $4 trillion as AI lifts stocks
-
Verstappen quells speculation by committing to Red Bull for 2026
-
Study reveals potato's secret tomato past
-
Trump's envoy in Israel as Gaza criticism mounts
-
Squiban solos to Tour de France stage win, Le Court maintains lead
-
Max Verstappen confirms he is staying at Red Bull next year
-
Mitchell keeps New Zealand on top against Zimbabwe
-
Vasseur signs new contract as Ferrari team principal
-
French cities impose curfews for teens to curb crime
-
Seals sing 'otherworldly' songs structured like nursery rhymes
-
India captain Gill run out in sight of Gavaskar record
-
Trump's global trade policy faces test, hours from tariff deadline
-
Study reveals potato's secret tomato heritage
-
Wirtz said I would 'enjoy' Bayern move, says Diaz
-
West Ham's Paqueta cleared of betting charges
-
AI gives stocks a lift, dollar mixed tracking Fed, tariffs
-
Authorities abandon recovery of German Olympian killed in Pakistan
-
Talks over France, Lions game 'progressing': Benazzi
-
Popovici ready to hit the beach after world swim sprint double
-
Magic Marchand adds gold to world record as McIntosh wins again
-
Sweden jihadist jailed for life over Jordan pilot burned alive
-
Zelensky signs bill ensuring anti-graft agencies' 'independence'
-
Sleepless in Singapore: Marchand wins gold, day after world record
-
England make early double strike in India series decider
-
Popovici wins 100m freestyle world gold for sprint double
-
Marchand wins 200m medley gold, day after world record
-
Thousands of Afghans scramble for chance to work in Qatar
-
Trump's envoy arrives in Israel as Gaza criticism mounts
-
McIntosh powers to third gold of worlds, 12-year-old Yu fourth
-
Hong Kong sees 3.1% growth in second quarter
-
Stocks, dollar mixed tracking Fed, tariffs, results
-
World Athletics brings in gene tests for female category eligibility
-
Trump says tariffs are making US 'great & rich' again
-
Pakistan opposition leader given 10 years for Imran Khan protests
-
India's Bumrah out of Oval finale as England bowl in fifth Test
-
Rights groups urge Nepal to reverse Telegram ban
-
BMW says can weather tariff storm despite profit plunge
-
Zelensky urges allies to push for 'regime change' in Russia
-
Renault profits slump as competition intensifies
-
Beijing officials admit 'gaps' in readiness after rains kill dozens
CMSC | 1.09% | 22.85 | $ | |
RYCEF | 7.62% | 14.18 | $ | |
RELX | 0.21% | 51.89 | $ | |
SCS | 0% | 10.33 | $ | |
RBGPF | 0.52% | 74.42 | $ | |
RIO | 0.47% | 59.77 | $ | |
BTI | 0.97% | 53.68 | $ | |
SCU | 0% | 12.72 | $ | |
BP | -0.31% | 32.15 | $ | |
GSK | -4.9% | 37.15 | $ | |
JRI | 0.15% | 13.13 | $ | |
VOD | -2.31% | 10.81 | $ | |
BCE | -0.86% | 23.33 | $ | |
BCC | -1.29% | 83.81 | $ | |
CMSD | 0.9% | 23.27 | $ | |
NGG | 0.28% | 70.39 | $ | |
AZN | -4.79% | 73.09 | $ |

Lantern Pharma Interview to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
ORLANDO, FLORIDA / ACCESS Newswire / July 25, 2025 / RedChip Companies will air an interview with Lantern Pharma Inc. (Nasdaq:LTRN) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, July 26, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.
Access the interview in its entirety at: https://www.redchip.com/assets/access/ltrn_access
In an exclusive interview, Panna Sharma, CEO of Lantern Pharma, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to discuss how Lantern is redefining oncology drug development through its proprietary AI platform, RADR®. Sharma highlights Lantern's clinical-stage programs (LP-300, LP-184, and LP-284) which address high-need indications such as NSCLC in never-smokers, DDR-deficient solid tumors, and aggressive lymphomas. He also shares how Lantern's capital-efficient AI-driven model, which has enabled 12 oncology programs in just two years at a fraction of traditional development costs, is driving rapid value creation. With multiple upcoming clinical readouts, an expanding AI-driven pipeline, and over 100 issued and pending patents, Lantern is positioned as a next-generation biotech innovator at the intersection of artificial intelligence and precision oncology.
LTRN is a client of RedChip Companies. Please read our full disclosure at https://www.redchip.com/legal/disclosures.
About Lantern Pharma
Lantern Pharma (NASDAQ:LTRN) is an AI-driven biotechnology company focused on accelerating and optimizing the discovery, development, and commercialization of cancer therapies. Its RADR® platform leverages artificial intelligence and machine learning to uncover novel therapeutic opportunities, accelerate drug development, and improve patient outcomes.
Please find more information at:
Website: www.lanternpharma.com
About RedChip Companies
RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on microcap and small-cap companies. For 33 years, RedChip has delivered concrete, measurable results for its clients. Our newsletter, Small Stocks, Big Money™, is delivered online weekly to 60,000 investors. RedChip has developed the most comprehensive service platform in the industry for microcap and small-cap companies. These services include the following: a worldwide distribution network for its stock research; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated millions of unique investor views; investor webinars and group calls; a television show, Small Stocks, Big Money™, which airs weekly on Bloomberg US; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more. RedChip also offers RedChat™, a proprietary AI-powered chatbot that analyzes SEC filings and corporate disclosures for all Nasdaq and NYSE-listed companies, giving investors instant, on-demand insights.
To learn more about RedChip's products and services, please visit:
https://www.redchip.com/corporate/investor_relations
"Discovering Tomorrow's Blue Chips Today"™
Follow RedChip on LinkedIn: https://www.linkedin.com/company/redchip/
Follow RedChip on Facebook: https://www.facebook.com/RedChipCompanies
Follow RedChip on Instagram: https://www.instagram.com/redchipcompanies/
Follow RedChip on Twitter: https://twitter.com/RedChip
Follow RedChip on YouTube: https://www.youtube.com/@redchip
Follow RedChip on Rumble: https://rumble.com/c/c-3068340
Subscribe to our Mailing List: https://www.redchip.com/newsletter/latest
Contact:
Dave Gentry
RedChip Companies Inc.
1-407-644-4256
[email protected]
--END--
SOURCE: RedChip Companies, Inc. (Media Suite)
View the original press release on ACCESS Newswire
F.Dubois--AMWN